Verrica PharmaceuticalsVRCA

13F holders, Q3 2025 (September 30)
2holders −52
0new positions
26sold out
$0.51avg. 13F price*

At the end of Q3 2025, 2 institutions reported holding Verrica Pharmaceuticals Inc. (VRCA) in their 13F filings, down 52 from Q2 2025. 0 opened new positions and 26 sold out. The largest holders were Osaic Holdings, Inc. ($301) and Cwm, LLC ($0).

Company
Verrica Pharmaceuticals Inc.
CUSIP
92511W108
Latest filing quarter
Q3 2025

History

Number of 13F holders

020406080100 Q1 2024: 62Q1 2024Q2 2024: 74Q2 2024Q3 2024: 79Q3 2024Q4 2024: 81Q4 2024Q1 2025: 75Q1 2025Q2 2025: 54Q2 2025Q3 2025: 2Q3 2025

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions0$0
Exits26$631K

All 13F filers, Q2 2025 → Q3 2025: 1,189,162 shares sold, net −1,189,162 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Osaic Holdings, Inc. 0.00% No change 568 $301
Cwm, LLC 0.00% Reduce -99.2% 28 $0

"% of holder's portfolio" is VRCA's weight in each manager's 13F, not the share of Verrica Pharmaceuticals Inc. the manager owns.